Islamic Azad University
Dr. Meena Subramanyam is the Vice President of the Development Translational Medicine Division at Biogen Idec, Inc., in Cambridge, Massachusetts. The division is involved in developing and validating bioanalytical assays to measure pharmacokinetics, pharmacodynamics and immunogenicity, as well as patient stratification assays to support translational medicine initiatives to monitor efficacy and/or toxicology/safety profile of drugs in Non-Clinical & Clinical Development. Dr. Subramanyam joined Biogen in 1998. Prior to that, Dr. Subramanyam served as Associate Director of the Experimental Therapeutics Department at Ares Advanced Technology of the Merck Serono group in Massachusetts.
development of transational medicine